Thermo Fisher Scientific TMO
NYSE TMO
$659.18 +10.75 (+1.66%)
As of: Sep 17, 2026 · 3:59 PM EDT

Thermo Fisher Scientific (TMO) Capital Expenditures (QoQ) (2009 - 2026)

Analysis

Thermo Fisher Scientific (TMO) Capital Expenditures (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 19.68%
Mar 28, 2026 -19.14%
Dec 31, 2025 15.10%
Sep 27, 2025 37.41%
Jun 28, 2025 -18.78%
Mar 29, 2025 -24.58%
Dec 31, 2024 76.47%
Sep 28, 2024 -9.63%
Jun 29, 2024 -13.26%
Mar 30, 2024 -14.32%
Dec 31, 2023 21.99%
Sep 30, 2023 16.90%
Jul 1, 2023 -37.99%
Apr 1, 2023 -16.73%
Dec 31, 2022 0.55%
Oct 1, 2022 8.10%
Jul 2, 2022 -20.94%
Apr 2, 2022 -22.98%
Dec 31, 2021 58.59%
Oct 2, 2021 -2.96%